Logotype for Adicet Bio Inc

Adicet Bio (ACET) investor relations material

Adicet Bio Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Adicet Bio Inc
Q3 2025 earnings summary5 Nov, 2025

Executive summary

  • Positive preliminary Phase 1 data for ADI-001 in lupus nephritis and SLE, with rapid and sustained reductions in disease activity and improved renal function; plans to initiate a Phase 2 pivotal trial in 2026.

  • Ongoing enrollment in Phase 1 studies for ADI-001 in multiple autoimmune indications, including LN, SLE, SSc, IIM, SPS, AAV, and treatment-refractory RA.

  • Regulatory filing for ADI-212 in metastatic castration-resistant prostate cancer planned for Q1 2026, with initial clinical data expected in 2H 2026.

  • Discontinued ADI-270 to prioritize resources on ADI-001 and ADI-212.

  • Completed $74.8 million capital raise in October 2025, extending cash runway into 2H 2027.

Financial highlights

  • Net loss for Q3 2025 was $26.9 million ($0.29 per share), a 12% improvement year-over-year; nine-month net loss was $86.3 million.

  • Operating expenses for Q3 2025 decreased 16% year-over-year to $28.0 million, with R&D at $22.9 million and G&A at $5.1 million.

  • Cash, cash equivalents, and short-term investments totaled $103.1 million as of September 30, 2025, with an additional $74.8 million raised in October 2025.

Outlook and guidance

  • Cash runway expected to fund operations into the second half of 2027, based on current cash and recent equity raise.

  • Clinical updates from Phase 1 studies of ADI-001 in LN, SLE, and SSc expected in 1H 2026; update for RA anticipated in 2H 2026.

  • Regulatory filing for ADI-212 in mCRPC planned for Q1 2026, with initial clinical data expected in 2H 2026.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Adicet Bio earnings date

Logotype for Adicet Bio Inc
Guggenheim Securities 2nd Annual Healthcare Innovation Conference11 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Adicet Bio earnings date

Logotype for Adicet Bio Inc
Guggenheim Securities 2nd Annual Healthcare Innovation Conference11 Nov, 2025

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Adicet Bio Inc. is a clinical-stage biotechnology company focused on the discovery and development of allogeneic gamma delta T cell therapies for cancer and other diseases. The company specializes in creating off-the-shelf genetically modified gamma delta T cells that selectively target tumors, leveraging the unique properties of these cells to offer a new generation of immune cell therapy. The company is headquartered in Redwood City, California, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage